Kurzfassung

AKC Studie: A multicenter, randomized, double-masked, parallel-group study evaluating the efficacy and safety of cyclosporine ophtalmic solution 0.010% compared with its vehicle administered QID for 3 months followed by a 9 month open-label phase in patients with atopic keraconjunctivitis